about
Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c miceA Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNAPassive tumor targeting and imaging by using mercaptosuccinic acid-coated near-infrared quantum dots.Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats.Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer.PEGylated Phospholipid Micelle-Encapsulated Near-Infrared PbS Quantum Dots for in vitro and in vivo BioimagingQuantum Dots-siRNA Nanoplexes for Gene Silencing in Central Nervous System Tumor Cells.Functionalized quantum dots for biosensing and bioimaging and concerns on toxicity.Assembling Mn:ZnSe quantum dots-siRNA nanoplexes for gene silencing in tumor cells.Preparation of biofunctionalized quantum dots using microfluidic chips for bioimaging.An electrochemically actuated MEMS device for individualized drug delivery: an in vitro study.Biodegradable nanocapsules as siRNA carriers for mutant K-Ras gene silencing of human pancreatic carcinoma cells.A Dual-Color Quantum Dots Encoded Frit-Based Immunoassay for Visual Detection of Aflatoxin M1 and Pirlimycin Residues in Milk.The future of quantum dots in drug discovery.Near-infrared fluorescent peptide probes for imaging of tumor in vivo and their biotoxicity evaluation.In vivo toxicity assessment of non-cadmium quantum dots in BALB/c mice.Cytotoxicity of InP/ZnS Quantum Dots With Different Surface Functional Groups Toward Two Lung-Derived Cell LinesFolic acid-conjugated organically modified silica nanoparticles for enhanced targeted delivery in cancer cells and tumor in vivo
P50
Q28386055-0FD1B0E7-9D87-4BEA-9EBE-06FBBF5A1A39Q28394647-7CA92FCA-598E-4F67-B213-D63046F54AEAQ34945653-D0D75FFF-F298-42E7-B175-CF3175BEC574Q35654369-B33878FB-3E44-4159-8B20-E22A64BDAD9AQ36078293-F342FEBE-761A-48E6-B193-A776ACF68CEAQ36163786-2F22EA57-3713-4294-8F8D-80236FF7BC92Q37736085-30F59AAA-3F9D-42BD-ABA7-BB1D52C7D5F5Q38080133-70CFF82D-5474-4046-BE8D-ED04859F84A0Q38848955-FF4D4043-08FC-4240-80CA-2E70CEC005EDQ38972441-980119E3-9B75-4200-8CC9-4894B05B07A8Q39180869-3D4593B0-6510-4A43-B024-CC7291A9C275Q39191239-5439307A-9C9F-4E34-BA45-49C5963B8AA6Q48249664-4D551979-6696-4E09-8A79-416543346254Q48879503-42AFE002-FE91-457B-946D-015CB806D628Q51597745-0F497A52-4243-4984-89FB-04CB657B1A97Q53373525-196F4B5F-1456-4FFC-B1A4-290D05146FDBQ57176140-13C23B22-EC4D-4152-95FB-EAE308F0B824Q60306441-BAE0C152-B0BF-4567-AAB5-CC0C7D77B0F1
P50
description
researcher ORCID ID = 0000-0002-6174-8923
@en
wetenschapper
@nl
name
Guimiao Lin
@ast
Guimiao Lin
@en
Guimiao Lin
@es
Guimiao Lin
@nl
type
label
Guimiao Lin
@ast
Guimiao Lin
@en
Guimiao Lin
@es
Guimiao Lin
@nl
prefLabel
Guimiao Lin
@ast
Guimiao Lin
@en
Guimiao Lin
@es
Guimiao Lin
@nl
P106
P1153
55354509300
P31
P496
0000-0002-6174-8923